Antipsychotic agents: A survey of the prevalence, severity and burden of side effects

被引:15
作者
Bhavnani, SM
Levin, GM
机构
[1] SUNY BUFFALO,CLIN PHARMACOKINET LAB,MILLARD FILLMORE HOSP,BUFFALO,NY
[2] ALBANY COLL PHARM,ALBANY,NY 12208
[3] CAPITAL DIST PSYCHIAT CTR,ALBANY,NY 12208
关键词
antipsychotic agents; patient-rated burden; severity; side effects;
D O I
10.1097/00004850-199603000-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We prospectively studied 64 male veteran out-patients with psychotic illnesses receiving one of six antipsychotic agents grouped by potency (low mid, high, atypical) to determine: (1) prevalence of side effects; (2) cumulative side effect burden; and (3) relationship between side effects and patient-perceived burden. Patients were administered a questionnaire which included: (1) demographic information; (2) prevalence of 49 side effects; (3) visual analog scales (VAS) rating the severity of 10 selected side effects; and (4) overall side effect burden scale, Outcome measures included comparison of the prevalence, severity and overall burden of side effects among the potency groups (Part A); and association between side effect prevalence and burden, the correlation between severity and burden of certain side effects and demographic variables for the entire population (Part B), In Part A some unexpected similarities and differences were seen among data collected; few significant differences were found between groups, an Part B, 11 of 49 side effects (22%) were significantly associated with burden; the severity of 9 of 10 side effects (90%) and two demographic variables were significantly correlated with burden. These findings suggest that the prevalence and severity of many side effects of antipsychotic agents may affect a patient's perception of side effect-related burden, The side effect burden ratings suggest that the low-potency agents were the most burdensome, while the atypical group was the least burdensome.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 32 条
[1]  
ABUZZAHAB FS, 1982, J CLIN PSYCHIAT, V43, P105
[2]  
ANGST J, 1975, ARZNEIMITTEL-FORSCH, V25, P267
[3]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[4]  
AWAD AG, 1992, HOSP COMMUNITY PSYCH, V43, P262
[5]  
BALDESSARINI RJ, 1984, AM J PSYCHIAT, V141, P748
[6]  
BAN TA, 1975, DIS NERV SYST, V36, P473
[7]   FREQUENCY OF DISTURBANCES OF LIVER-FUNCTION, LEUCOPOESIS, BLOOD-PRESSURE AND TEMPERATURE REGULATION UNDER CLOZAPINE IN COMPARISON WITH PERAZINE AND HALOPERIDOL [J].
BAUER, D ;
GAERTNER, HJ .
PHARMACOPSYCHIATRIA, 1983, 16 (01) :23-29
[8]  
BRESSLER B, 1971, PSYCHOSOMATICS, V12, P275
[9]   COMPARISON OF ANTIPSYCHOTIC DEPOT INJECTIONS IN MAINTENANCE TREATMENT OF SCHIZOPHRENIA [J].
CARNEY, MWP ;
SHEFFIELD, BF .
BRITISH JOURNAL OF PSYCHIATRY, 1976, 129 (NOV) :476-481
[10]  
CRISMON ML, 1992, PHARMACOTHERAPY PATH, P1020